The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Open accessAbstract
OBJECTIVES: The cytokine interleukin (IL)-1 mediates ischaemic brain damage in rodents. The endogenous, highly selective, IL-1 receptor antagonist (IL-1ra) protects against ischaemic cerebral injury in a range of experimental settings, and IL-1ra causes a marked reduction of cell death when administered peripherally or at a delay in transient cerebral ischaemia. We report here the first randomised, double blind, placebo controlled trial of recombinant human IL-1ra (rhIL-1ra) in patients with acute stroke. METHODS: Patients within 6 hours of the onset of symptoms of acute stroke were randomised to rhIL-1ra or matching placebo. Test treatment was administered intravenously by a 100 mg loading dose over 60 seconds, followed by a 2 mg/kg/h infusion over 72 h. Adverse events and serious adverse events were recorded for up to 3 months, serial blood samples were collected for biological markers up to 3 months, and 5-7 day brain infarct volume was measured by computed tomography. RESULTS: No adverse events were attributed to study treatment among 34 patients randomised. Markers of biological activity, including neutrophil and total white cell counts, C reactive protein, and IL-6 concentrations, were lower in rhIL-1ra treated patients. Among patients with cortical infarcts, clinical outcomes at 3 months in the rhIL-1ra treated group were better than in placebo treated. CONCLUSIONS: These data suggest that rhIL-1ra is safe and well tolerated in acute stroke. In addition, rhIL-1ra exhibited biological activity that is relevant to the pathophysiology and clinical outcome of ischaemic stroke. Our findings identify rhIL-1ra as a potential new therapeutic agent for acute stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1965) · PubMed · Cited by 14,925
Functional evaluation : Barthel index
Mahonery, F. I. (1965) · Medical Entomology and Zoology · Cited by 12,762
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
The Medical Dictionary for Regulatory Activities (MedDRA)
Brown, E. G., Wood, L., & Wood, S. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00002 · Cited by 1,390
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
Lyden, P., Brott, T., Tilley, B., Welch, K. M., Mascha, E. J., Levine, S., Haley, E. C., Grotta, J., & Marler, J. (1994) · Stroke · doi:10.1161/01.str.25.11.2220 · Cited by 1,285
Medical Complications After Stroke: A Multicenter Study
Langhorne, P., Stott, D. J., Robertson, L., MacDonald, J., Jones, L., McAlpine, C., Dick, F., Taylor, G. S., & Murray, G. (2000) · Stroke · doi:10.1161/01.str.31.6.1223 · Cited by 1,196
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
The balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
Interobserver agreement for the assessment of handicap in stroke patients.
Bamford, J. M., Sandercock, P. A., Warlow, C. P., & Slattery, J. (1989) · Stroke · doi:10.1161/01.str.20.6.828 · Cited by 693
Inflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. J. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
Fisher, C. J., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., & Catalano, M. A. (1994) · Critical Care Medicine · doi:10.1097/00003246-199401000-00008 · Cited by 490
Smith, C. J., Emsley, H. C., Gavin, C. M., Georgiou, R. F., Vail, A., Barberan, E. M., del Zoppo, G. J., Hallenbeck, J. M., Rothwell, N. J., Hopkins, S. J., et al. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-2 · Cited by 480
Self-citationIschemic Penumbra: Evidence From Functional Imaging in Man
Heiss, W.-D. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200009000-00002 · Cited by 367
Acute inflammatory reaction following experimental intracerebral hemorrhage in rat
Gong, C., Hoff, J. T., & Keep, R. F. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02427-6 · Cited by 334
Emsley, H. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00134-6 · Cited by 301
Self-citationInterleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential
Rothwell, N. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00098-3 · Cited by 291
Toulmond, S., & Rothwell, N. J. (1995) · Brain Research · doi:10.1016/0006-8993(94)01343-g · Cited by 248
Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke
Beamer, N. B., Coull, B. M., Clark, W. M., Hazel, J. S., & Silberger, J. R. (1995) · Annals of Neurology · doi:10.1002/ana.410370614 · Cited by 231
Potential mechanisms of interleukin-1 involvement in cerebral ischaemia
Touzani, O., Boutin, H., Chuquet, J., & Rothwell, N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00202-7 · Cited by 230
Does the National Institutes of Health Stroke Scale Favor Left Hemisphere Strokes?
Woo, D., Broderick, J. P., Kothari, R. U., Lu, M., Brott, T., Lyden, P. D., Marler, J. R., & Grotta, J. C. (1999) · Stroke · doi:10.1161/01.str.30.11.2355 · Cited by 225
Mulcahy, N. J., Ross, J., Rothwell, N. J., & Loddick, S. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705462 · Cited by 185
Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier
GUTIERREZ, E., BANKS, W., & KASTIN, A. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90005-1 · Cited by 175
Martin, D., Chinookoswong, N., & Miller, G. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1215 · Cited by 162
MRC Guidelines for Good Clinical Practice in Clinical Trials
Vere, D. (1999) · Journal of Medical Ethics · doi:10.1136/jme.25.3.280-a · Cited by 159
Heterogeneity of Stroke Pathophysiology and Neuroprotective Clinical Trial Design
Muir, K. W. (2002) · Stroke · doi:10.1161/01.str.0000018684.86293.ab · Cited by 103
Siddique, M. S., Fernandes, H. M., Wooldridge, T. D., Fenwick, J. D., Slomka, P. J., & Mendelow, A. D. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.4.0736 · Cited by 102
Masada, T., Hua, Y., Xi, G., Yang, G., Hoff, J. T., & Keep, R. F. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.4.0680 · Cited by 97
Human cellular inflammation in the pathology of acute cerebral ischaemia
Price, C. J. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.11.1476 · Cited by 63
Kidney as a Major Clearance Organ for Recombinant Human Interleukin‐1 Receptor Antagonist
Kim, D., Carmichael, D. F., Reitz, B., & Bloedow, D. C. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840511 · Cited by 32
Grundy, R. I., Rothwell, N. J., & Allan, S. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01377-3 · Cited by 16
Reliability of a Semi-Automated Technique of Cerebral Infarct Volume Measurement with CT
Gavin, C. M., Smith, C. J., Emsley, H. C. A., Hughes, D. G., Turnbull, I. W., Vail, A., & Tyrrell, P. J. (2004) · Cerebrovascular Diseases · doi:10.1159/000079957 · Cited by 11
Self-citation
Cited by
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
The inflammatory response in stroke
Wang, Q., Tang, X. N., & Yenari, M. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.014 · Cited by 1,177
Metadata
- Authors
- Emsley, H. C. A.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2005-10-01
- Volume
- 76
- Issue
- 10
- Pages
- 1366-1372
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W1981724301
- Cited by
- 445
- References
- 33
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.